Aug 19, 2019, 11:14 AM
Fulcrum Therapeutics Announces Initiation of ReDUX4, a Phase 2b Clinical Trial of Losmapimod for FSHD.
Progress Update: Optimizing the Utility of the National Registry for FSHD Research and Trial Recruitment
Aug 5, 2019, 10:19 AM
Dr. Tawil provides an update on year three of his project to get genetic testing performed for those in the registry who do not have it, and thus create a larger viable pool for upcoming clinical trials.
Aug 2, 2019, 10:18 AM
Travel reports from recipients of travel grants for the 2019 FSH Society International Research Congress.
Aug 1, 2019, 5:52 PM
Sujatha Jagannathan provides a brief final summary of work on her research.
Aug 1, 2019, 12:24 PM
Yi-Wen Chen provides a final summary of her research activities.
Aug 1, 2019, 12:08 PM
Dr. Tawil provides a brief update on the two CTRN European sites funded.